All Stories

  1. Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997–2011
  2. Bias analyses to investigate the impact of differential participation: Application to a birth defects case‐control study
  3. Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy
  4. Trends in congenital clubfoot prevalence and co-occurring anomalies during 1994–2021 in Denmark: a nationwide register-based study
  5. Using a health observance event to raise awareness: An assessment of World Birth Defects Day
  6. Trends in congenital clubfoot prevalence and co-occurring anomalies during 1994-2021 in Denmark: A nationwide register-based study of 1,315,282 live born infants
  7. Maternal dietary caffeine consumption and risk of birth defects in the National Birth Defects Prevention Study , 1997–2011
  8. Assessing associations between residential proximity to greenspace and birth defects in the National Birth Defects Prevention Study
  9. TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis
  10. Pregnancy and infant outcomes by trimester of SARS‐CoV ‐2 infection in pregnancy– SET‐NET , 22 jurisdictions, January 25, 2020–December 31, 2020
  11. Targeted Sequencing of Candidate Regions Associated with Sagittal and Metopic Nonsyndromic Craniosynostosis
  12. Time to Diagnosis of Duchenne Muscular Dystrophy Remains Unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network ( MD STAR net ), 2...
  13. Patterns of multiple congenital anomalies in the National Birth Defect Prevention Study: Challenges and insights
  14. Factors associated with maternal consent for use of residual newborn bloodspots in the National Birth Defects Prevention Study
  15. Direct costs of adhering to selected Duchenne muscular dystrophy care considerations: estimates from a Midwestern state
  16. Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study
  17. Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
  18. Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
  19. Association between maternal periconceptional alcohol consumption and neural tube defects: Findings from the National Birth Defects Prevention Study, 1997–2011
  20. Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy
  21. Pre‐pregnancy dietary arsenic consumption among women in the United States
  22. Population‐based birth defects data in the United States, 2012–2016: A focus on abdominal wall defects
  23. Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015
  24. Quantifying geographic regions of excess stillbirth risk in the presence of spatial and spatio-temporal heterogeneity
  25. Needs management in families affected by childhood-onset dystrophinopathies
  26. Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population‐based retrospective study, 1999–2010
  27. Maternal arsenic exposure and nonsyndromic orofacial clefts
  28. A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017
  29. A population-based case-control study of the association between weather-related extreme heat events and orofacial clefts
  30. Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study
  31. Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011
  32. Maternal occupational cadmium exposure and nonsyndromic orofacial clefts
  33. Copy number variants in Ebstein anomaly
  34. Clinical and risk factor analysis of cloacal defects in the National Birth Defects Prevention Study
  35. Population-based case-control study of the association between weather-related extreme heat events and neural tube defects
  36. Copy-number variants and candidate gene mutations in isolated split hand/foot malformation
  37. Application of the International Classification of Functioning, Disability and Health system to symptoms of the Duchenne and Becker muscular dystrophies
  38. Factors associated with employment status before and during pregnancy: Implications for studies of pregnancy outcomes
  39. Identifying birth defects in automated data sources in the Vaccine Safety Datalink
  40. Genetic Variants in Isolated Ebstein Anomaly Implicated in Myocardial Development Pathways
  41. Maternal periconceptional alcohol consumption and congenital heart defects
  42. Genitourinary health in a population-based cohort of males with Duchenne and Becker Muscular dystrophies
  43. Stillbirth surveillance consortium
  44. Neurobehavioral Concerns Among Males with Dystrophinopathy Using Population-Based Surveillance Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network
  45. Indirect and Direct Perceived Behavioral Control and the Role of Intention in the Context of Birth Control Behavior
  46. Novel copy-number variants in a population-based investigation of classic heterotaxy
  47. Maternal periconceptional alcohol consumption and congenital limb deficiencies
  48. Maternal periconceptional occupational pesticide exposure and neural tube defects
  49. Assessing bottled water nitrate concentrations to evaluate total drinking water nitrate exposure and risk of birth defects
  50. Complementary and Alternative Medicine for Duchenne and Becker Muscular Dystrophies: Characteristics of Users and Caregivers
  51. Examination of Mental Health Status and Aggravation Level Among Mothers of Children With Isolated Oral Clefts
  52. Exploring Maternal Patterns of Dietary Caffeine Consumption Before Conception and During Pregnancy
  53. Descriptive and risk factor analysis for choanal atresia: The National Birth Defects Prevention Study, 1997–2007
  54. Maternal periconceptional occupational exposure to pesticides and selected musculoskeletal birth defects
  55. Maternal Hypertension, Medication Use, and Hypospadias in the National Birth Defects Prevention Study
  56. Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings
  57. Maternal Caffeine Consumption and Small for Gestational Age Births: Results from a Population-Based Case–Control Study
  58. Self-Reported Maternal Cigarette Smoke Exposure during the Periconceptional Period and the Risk for Omphalocoele
  59. Factors affecting maternal participation in the genetic component of the National Birth Defects Prevention Study—United States, 1997–2007
  60. Plasma Lipids, Genetic Variants Near APOA1 , and the Risk of Infantile Hypertrophic Pyloric Stenosis
  61. Maternal Periconceptional Exposure to Cigarette Smoking and Congenital Limb Deficiencies
  62. Cancer Risk in Children and Adolescents with Birth Defects: A Population-Based Cohort Study
  63. Maternal Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Risk of Oral Cleft-Affected Pregnancies
  64. The association of low socioeconomic status and the risk of having a child with Down syndrome: a report from the National Down Syndrome Project
  65. Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study
  66. Periconceptional maternal alcohol consumption and neural tube defects
  67. Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: A report from the National Down Syndrome Project
  68. Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy
  69. Anorectal atresia and Variants at Predicted Regulatory Sites in Candidate Genes
  70. Evaluation of genes involved in limb development, angiogenesis, and coagulation as risk factors for congenital limb deficiencies
  71. O-090
  72. Maternal caffeine consumption and risk of congenital limb deficiencies
  73. Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations
  74. Analysis of selected maternal exposures and non-syndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005.
  75. Effect of survey instrument on participation in a follow-up study: a randomization study of a mailed questionnaire versus a computer-assisted telephone interview
  76. Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect‐affected pregnancies
  77. Hirschsprung’s disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation
  78. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects
  79. Maternal Occupational Exposure to Polycyclic Aromatic Hydrocarbons: Effects on Gastroschisis among Offspring in the National Birth Defects Prevention Study
  80. Folate and vitamin B12-related genes and risk for omphalocele
  81. Use of active surveillance methodologies to examine over-reporting of stillbirths on fetal death certificates
  82. Maternal occupational pesticide exposure and risk of hypospadias in the national birth defects prevention study
  83. Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis
  84. Maternal caffeine intake and risk of selected birth defects in the national birth defects prevention study
  85. Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects
  86. Maternal smoking, passive tobacco smoke, and neural tube defects
  87. Primary care physician experience with children with oral clefts in three states
  88. Maternal periconceptional exposure to cigarette smoking and alcohol consumption and congenital diaphragmatic hernia
  89. Prenatal Diagnosis of Orofacial Clefts: Association With Maternal Satisfaction, Team Care, and Treatment Outcomes
  90. Identification of Iowa Live Births in the Agricultural Health Study
  91. Epidemiology of congenital idiopathic talipes equinovarus in Iowa, 1997-2005
  92. Caffeine, selected metabolic gene variants, and risk for neural tube defects
  93. Patterns of tobacco exposure before and during pregnancy
  94. Maternal characteristics associated with the dietary intake of nitrates, nitrites, and nitrosamines in women of child-bearing age: a cross-sectional study
  95. Interdisciplinary Craniofacial Teams Compared With Individual Providers: Is Orofacial Cleft Care More Comprehensive and Do Parents Perceive Better Outcomes?
  96. Maternal caffeine consumption and risk of neural tube defects
  97. Demographic Characteristics, Care, and Outcomes for Children With Oral Clefts in Three States Using Participants From the National Birth Defects Prevention Study
  98. Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
  99. Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study
  100. Demographic Characteristics, Care and Outcomes for Children with Oral Clefts in Three States Using Participants from the National Birth Defects Prevention Study
  101. Maternal Reports of Satisfaction with Care and Outcomes for Children with Microtia
  102. Pesticides and hypospadias: A meta-analysis
  103. Bayesian Methods for Correcting Misclassification
  104. Maternal Reports of Satisfaction With Care and Outcomes for Children With Craniosynostosis
  105. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects
  106. Maternal periconceptional exposure to cigarette smoking and alcohol and esophageal atresia ± tracheo-esophageal fistula
  107. Maternal Smoking and Congenital Heart Defects
  108. Alcohol Consumption by Women Before and During Pregnancy
  109. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project
  110. Antifungal drugs and the risk of selected birth defects
  111. Maternal reports of family history from the National Birth Defects Prevention Study, 1997–2001
  112. Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias
  113. Meta-Analysis: Pesticides and Orofacial Clefts
  114. Maternal caffeine consumption and risk of cardiovascular malformations
  115. Maternal Smoking and Environmental Tobacco Smoke Exposure and the Risk of Orofacial Clefts
  116. Periconceptional consumption of vitamins containing folic acid and risk for multiple congenital anomalies
  117. Orofacial Cleft Risk Is Increased with Maternal Smoking and Specific Detoxification-Gene Variants
  118. Ultrasound findings in 34 cases of trisomy 13
  119. Type of Oral Cleft and Mothers' Perceptions of Care, Health Status, and Outcomes for Preadolescent Children
  120. PVRL1 variants contribute to non-syndromic cleft lip and palate in multiple populations
  121. The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Surveillance methodology
  122. In vitro fertilization is associated with an increase in major birth defects
  123. The use of pesticides in a Polish rural population and its effect on birth weight
  124. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genesMTHFR,MTHFD,MTRR,RFC1, andGCP2
  125. Complex segregation analysis of 1,792 cleft lip and palate families in South America: 1967-1997
  126. Integration of DNA sample collection into a multi-site birth defects case-control study
  127. Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2): Structure, gene mapping, polymorphisms, and candidate evaluation for human orofacial clefts
  128. Acceptability of Telepsychiatry to a Rural Population
  129. Evaluation of reports of periconceptual occupational exposure: Maternal‐assessed versus industrial hygienist‐assessed exposure
  130. Evaluation of reports of periconceptual occupational exposure: Maternal-assessed versus industrial hygienist-assessed exposure
  131. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts
  132. Association of MSX1 and TGFB3 with Nonsyndromic Clefting in Humans
  133. Maternal interview reports of family history of birth defects: Evaluation from a population-based case-control study of orofacial clefts
  134. Feasibility of Collecting Disease Reports from Relatives for Genetic Epidemiologic Investigations
  135. Maternal alcohol use and risk of orofacial cleft birth defects